fluorouracil has been researched along with magnesium sulfate in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 4 (57.14) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Boisdron-Celle, M; Delva, R; Gamelin, E; Gamelin, L; Guérin-Meyer, V; Ifrah, N; Morel, A | 1 |
| Donovan, CT; Ferencz, TM; McGurk, ML; Saif, MW; Wrzesinski, SH | 1 |
| Dong, M; Feng, FY; Liu, P; Shi, YK; Xing, PY | 1 |
| Chay, WY; Choo, SP; Gao, F; Koo, WH; Lo, YL; Ng, HC; Ong, SY; Tan, SH | 1 |
| Alberts, S; Ansari, R; Childs, BH; Chowhan, N; Grothey, A; Hainsworth, JD; Hart, L; Hochster, HS; Keaton, M; Ramanathan, RK; Rowland, K | 1 |
| Dosaka-Akita, H; Honma, R; Iseki, K; Kasashi, K; Kinoshita, I; Kobayashi, M; Saito, Y; Shimizu, Y; Takeuchi, S; Yamada, T | 1 |
| Saito, Y | 1 |
1 review(s) available for fluorouracil and magnesium sulfate
| Article | Year |
|---|---|
[Clinical and Fundamental Approach for Chemotherapy-induced Adverse Effect Attenuation by Oncology Pharmacy Specialists].
Topics: Animals; Antineoplastic Agents; Antiporters; Cisplatin; Docetaxel; Drug-Related Side Effects and Adverse Reactions; Fluorouracil; Gene Expression; Gene Expression Regulation, Neoplastic; Humans; Magnesium Sulfate; Medical Oncology; Organic Cation Transport Proteins; Organic Cation Transporter 2; Pharmacists; Premedication; Rats; Specialization | 2020 |
3 trial(s) available for fluorouracil and magnesium sulfate
| Article | Year |
|---|---|
[Assessment of the protective effect of calcium-magnesium infusion and glutathione on oxaliplatin-induced neurotoxicity].
Topics: Adolescent; Adult; Aged; Anticonvulsants; Antineoplastic Combined Chemotherapy Protocols; Calcium Gluconate; Colorectal Neoplasms; Double-Blind Method; Drug Therapy, Combination; Female; Fluorouracil; Glutathione; Humans; Infusions, Intravenous; Leucovorin; Magnesium Sulfate; Male; Middle Aged; Neurotoxicity Syndromes; Organoplatinum Compounds; Stomach Neoplasms; Young Adult | 2010 |
Use of calcium and magnesium infusions in prevention of oxaliplatin induced sensory neuropathy.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Calcium Gluconate; Capecitabine; Cohort Studies; Colorectal Neoplasms; Deoxycytidine; Female; Fluorouracil; Humans; Infusions, Intravenous; Leucovorin; Magnesium Sulfate; Male; Middle Aged; Neurotoxicity Syndromes; Organoplatinum Compounds; Oxaliplatin; Paresthesia; Retrospective Studies; Treatment Outcome; Young Adult | 2010 |
Improved time to treatment failure with an intermittent oxaliplatin strategy: results of CONcePT.
Topics: Adult; Aged; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Calcium Gluconate; Colorectal Neoplasms; Double-Blind Method; Female; Fluorouracil; Humans; Kaplan-Meier Estimate; Leucovorin; Magnesium Sulfate; Male; Middle Aged; Organoplatinum Compounds; Oxaliplatin; Proportional Hazards Models | 2014 |
3 other study(ies) available for fluorouracil and magnesium sulfate
| Article | Year |
|---|---|
Prevention of oxaliplatin-related neurotoxicity by calcium and magnesium infusions: a retrospective study of 161 patients receiving oxaliplatin combined with 5-Fluorouracil and leucovorin for advanced colorectal cancer.
Topics: Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Calcium; Calcium Gluconate; Chelating Agents; Female; Fluorouracil; Humans; Laryngismus; Leucovorin; Magnesium; Magnesium Sulfate; Male; Middle Aged; Organoplatinum Compounds; Oxaliplatin; Paresthesia; Retrospective Studies; Time Factors; Treatment Outcome | 2004 |
Successful desensitization to oxaliplatin with incorporation of calcium gluconate and magnesium sulfate.
Topics: Adenocarcinoma; Adult; Antineoplastic Combined Chemotherapy Protocols; Calcium Gluconate; Drug Hypersensitivity; Female; Fluorouracil; Humans; Leucovorin; Magnesium Sulfate; Neoplasm Staging; Organoplatinum Compounds; Oxaliplatin; Sigmoid Neoplasms; Treatment Outcome | 2007 |
Premedication with intravenous magnesium has a protective effect against cisplatin-induced nephrotoxicity.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Dietary Supplements; Docetaxel; Female; Fluorouracil; Head and Neck Neoplasms; Humans; Kidney; Kidney Diseases; Magnesium; Magnesium Deficiency; Magnesium Sulfate; Male; Middle Aged; Premedication; Retrospective Studies; Taxoids | 2017 |